---
title: "SS Innovations Achieves Milestone with First Robotic Telesurgery"
description: "SS Innovations International (SSII) announced the successful completion of its first robotic telesurgery using the MantraM mobile unit on September 9, 2025. Conducted by Dr. Priya Bhave Chittawar, the"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256575361.md"
published_at: "2025-09-09T12:59:28.000Z"
---

# SS Innovations Achieves Milestone with First Robotic Telesurgery

> SS Innovations International (SSII) announced the successful completion of its first robotic telesurgery using the MantraM mobile unit on September 9, 2025. Conducted by Dr. Priya Bhave Chittawar, the complex hysterectomy was performed remotely in Bhopal, India. The company aims to provide advanced surgical care to underserved populations. Analyst ratings for SSII stock are mixed, with a Hold rating and a $6.00 price target, while Spark's AI Analyst rates it as Neutral due to strong corporate events but concerns over financial performance and valuation metrics.

SS Innovations International ( (SSII) ) just unveiled an update.

On September 9, 2025, SS Innovations International announced the successful completion of the first robotic telesurgery performed from its MantraM mobile robotic telesurgery unit. This milestone, achieved by Dr. Priya Bhave Chittawar, involved a complex hysterectomy conducted remotely in Bhopal, India, highlighting the company’s mission to provide advanced surgical care to underserved populations. The MantraM bus tour, launched in July 2025 across India, aims to demonstrate the capabilities of SS Innovations’ mobile unit and SSi Mantra system, focusing on hospitals and medical institutions in underserved communities.

The most recent analyst rating on (SSII) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.

**Spark’s Take on SSII Stock**

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

SS Innovations International’s score is primarily driven by its strong corporate events, which highlight significant achievements and growth potential. However, financial performance issues, particularly in profitability and cash flow, along with a bearish technical outlook and poor valuation metrics, weigh heavily on the overall score.

To see Spark’s full report on SSII stock, click here.

**More about SS Innovations International**

SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. Their product range includes the proprietary ‘SSi Mantra’ surgical robotic system and ‘SSi Mudra’ surgical instruments, supporting various procedures including robotic cardiac surgery. The company, headquartered in India, plans to expand its global presence with its advanced, user-friendly, and cost-effective solutions.

**Average Trading Volume:** 227,017

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $1.36B

For a thorough assessment of SSII stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [SSII.US - SS Innovations](https://longbridge.com/en/quote/SSII.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| SS Innovations｜8-K：2025 财年 Q4 营收 15 百万美元 |  | [Link](https://longbridge.com/en/news/272421159.md) |
| SS Innovations 发布了用于儿科和心脏护理的新型 5 毫米机器人手术器械 | SS Innovations International Inc. 已完成五种新的 5mm 外科手术器械的开发，旨在增强其 SSi Mantra 机器人系统在儿科和心脏手术中的应用。这些器械包括刮刀电刀、钩电刀、针持器、双极镊子和抓取镊子， | [Link](https://longbridge.com/en/news/271657671.md) |
| 智元发布新一代全尺寸人形机器人远征 A3 | 智元机器人于 2 月 13 日发布了新一代全尺寸人形机器人远征 A3，专注于导览导购和文娱商演等人机互动场景。该机器人具备超拟人全身自由度，手臂负载可达 3kg，最高速度为 2m/s，配备灵巧手。其创新的电池嵌入式躯干设计和双电池系统使其在 | [Link](https://longbridge.com/en/news/275868234.md) |
| 瑞银：预计 2026 年人形机器人需求 3 万台，真正放量或在 2027—2028 年 | 瑞银报告指出，人形机器人正加速从概念验证迈向工业应用，2026 年全球需求量预计达 3 万台，若 AI 技术突破或客户反馈积极，乐观情境下可达 4 万台。2025 年全球出货约 1.86 万台，中国企业宇树科技与智元机器人合计出货近万台，占 | [Link](https://longbridge.com/en/news/275780289.md) |
| All in AI！别再把特斯拉看成汽车公司 | 德银预计，特斯拉计划将资本支出提高一倍以上，可能超过 200 亿美元，其中大部分资金将投向 AI 训练系统、数据中心、定制芯片、机器人工厂和新平台，而非汽车。公司 FSD 订阅业务将产生高达 100 亿美元年收入，Robotaxi 年收入也 | [Link](https://longbridge.com/en/news/274602819.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.